Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-13
2007-02-13
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S137000
Reexamination Certificate
active
11128238
ABSTRACT:
There is provided an acid addition salt of (−)-(3R)-quinuclidin-3-yl(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate with an acid selected from the group consisting of (−)-(2S,3S)-tartaric acid, (+)-(2S,3S)-di-O-benzoyltartaric acid, (+)-(2S,3S)-di-O-(4-methylbenzoyl)tartaric acid, (−)-L-phenylalanine, benzenesulfonic acid, cyclohexanesulfamic acid, hydrobromic acid, naphthalene-2-sulfonic acid, sebacic acid, (+)-camphor-10-sulfonic acid, p-toluenesulfonic acid, ethanesulfonic acid, methanesulfonic acid and methyl phosphate, which has little hygroscopicity that affects the use as a drug or its drug substance, and is very useful as a drug or its drug substance.
REFERENCES:
patent: 6017917 (2000-01-01), Kuno et al.
patent: 0 801 067 (1997-10-01), None
patent: 3701964 (1991-04-01), None
patent: 10/007675 (1998-01-01), None
patent: 2002/104968 (2002-04-01), None
patent: WO 1996/020194 (1996-07-01), None
International Search Rreport for PCT/JP2006/304241.
Hayakawa Masahiko
Ikeda Ken
Samizu Kiyohiro
Takeuchi Makoto
Uebayashi Hiroshi
Astellas Pharma Inc.
Owens Amelia A.
LandOfFree
Salts of quinuclidine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salts of quinuclidine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salts of quinuclidine derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3816990